Published in Eur J Clin Pharmacol on January 01, 1996
Orlistat. No hurry.... Can Fam Physician (1999) 0.86
Blood pressure control by the renin-angiotensin system in normotensive subjects. Assessment by angiotensin converting enzyme and renin inhibition. Circulation (1992) 2.15
Captopril-associated agranulocytosis. Lancet (1980) 1.61
Variability in nifedipine pharmacokinetics and dynamics: a new oxidation polymorphism in man. Biochem Pharmacol (1984) 1.60
Antihypertensive and renal effects of captopril in relation to renin activity and bradykinin-induced vasodilation. Clin Pharmacol Ther (1982) 1.51
Effect of propofol on peripheral vascular resistance during cardiopulmonary bypass. Br J Anaesth (1990) 1.44
An evaluation of the integration of pharmacokinetic and pharmacodynamic principles in clinical drug development. Experience within Hoffmann La Roche. Clin Pharmacokinet (1997) 1.37
Protocatechuic acid induces cell death in HepG2 hepatocellular carcinoma cells through a c-Jun N-terminal kinase-dependent mechanism. Cell Biol Toxicol (2006) 1.35
Nifedipine: kinetics and dynamics in healthy subjects. Clin Pharmacol Ther (1984) 1.32
Influence of sodium intake on hydrochlorothiazide-induced changes in blood pressure, serum electrolytes, renin and aldosterone in essential hypertension. Acta Med Scand (1978) 1.19
Factors regulating the cytotoxic activity of the human natural killer cell line, NK-92. J Hematother Stem Cell Res (2001) 1.18
Age-related decrease in cardiac and peripheral vascular responsiveness to isoprenaline: studies in normal subjects. Clin Sci (Lond) (1981) 1.14
Hemodynamic changes during long-term thiazide treatment of essential hypertension in responders and nonresponders. Clin Pharmacol Ther (1980) 1.12
Identification of vascular postsynaptic alpha 1- and alpha 2-adrenoceptors in man. Circ Res (1984) 1.09
Integrated pharmacokinetics and pharmacodynamics of the novel catechol-O-methyltransferase inhibitor tolcapone during first administration to humans. Clin Pharmacol Ther (1995) 1.06
Arterial thromboembolic complications with aortic ball valve prostheses. Am Heart J (1978) 1.04
Modulation of noradrenaline release by peripheral presynaptic alpha 2-adrenoceptors in humans. J Cardiovasc Pharmacol (1987) 1.01
Nifedipine: influence of renal function on pharmacokinetic/hemodynamic relationship. Clin Pharmacol Ther (1985) 0.99
Regional vascular effects of serotonin and ketanserin in young, healthy subjects. Hypertension (1988) 0.99
Rate of increase in the plasma concentration of nifedipine as a major determinant of its hemodynamic effects in humans. Clin Pharmacol Ther (1987) 0.98
Effects of a new long-acting beta-blocker bopindolol (LT 31-200) on blood pressure, plasma catecholamines, renin and cholesterol in patients with arterial hypertension. Eur J Clin Pharmacol (1982) 0.97
Plasma noradrenaline concentration and alpha-adrenoceptor-mediated vasoconstriction in normotensive and hypertensive man. Clin Sci (Lond) (1981) 0.95
Antihypertensive efficacy of the new long-acting beta-blocker bopindolol as related to age. J Cardiovasc Pharmacol (1983) 0.94
Negligible sublingual absorption of nifedipine. Lancet (1987) 0.93
Multiple-dose clinical pharmacology of the catechol-O-methyl-transferase inhibitor tolcapone in elderly subjects. Eur J Clin Pharmacol (1996) 0.92
Effects of intravenous lipid as a source of energy in parenteral nutrition associated hepatic dysfunction and lidocaine elimination: a study using isolated rat liver perfusion. Biopharm Drug Dispos (1997) 0.92
Nifedipine: kinetics and hemodynamic effects in patients with liver cirrhosis after intravenous and oral administration. Clin Pharmacol Ther (1986) 0.92
Nifedipine kinetics and dynamics during rectal infusion to steady state with an osmotic system. Clin Pharmacol Ther (1984) 0.91
Pharmacokinetics of intravenous cefetamet and oral cefetamet pivoxil in patients with renal insufficiency. Antimicrob Agents Chemother (1989) 0.91
Acute vasodilator action of pindolol in humans. Hypertension (1985) 0.90
The effects of exercise on the pharmacokinetics of drugs. J Pharm Pharm Sci (2001) 0.89
Does regional norepinephrine spillover represent local sympathetic activity? Hypertension (1991) 0.89
Alpha-adrenergic receptors in human blood vessels. Br J Clin Pharmacol (1986) 0.89
Plasma catecholamines and cardiac, renal and peripheral vascular adrenoceptor-mediated responses in different age groups of normal and hypertensive subjects. Clin Exp Hypertens (1980) 0.89
Pharmacokinetics of oral cefetamet pivoxil (Ro 15-8075) and intravenous cefetamet (Ro 15-8074) in humans: a review. Curr Med Res Opin (1989) 0.88
The contribution of nisoldipine-induced changes in liver blood flow to its pharmacokinetics after oral administration. Br J Clin Pharmacol (1989) 0.88
Nifedipine. Relationship between pharmacokinetics and pharmacodynamics. Clin Pharmacokinet (1987) 0.87
The relevance of intrinsic sympathomimetic activity for beta-blocker-induced changes in plasma lipids. J Cardiovasc Pharmacol (1983) 0.87
Ethnopharmacology of rhinoceros horn. I: Antipyretic effects of rhinoceros horn and other animal horns. J Ethnopharmacol (1990) 0.86
Prolonged blood pressure reduction by orally active renin inhibitor RO 42-5892 in essential hypertension. BMJ (1990) 0.86
A microcomputer-based, R-wave triggered system for hemodynamic measurements in the forearm. Comput Biol Med (1988) 0.86
Norepinephrine removal and release in the forearm of healthy subjects. Hypertension (1986) 0.85
Effects of 5-hydroxytryptamine on capillary and arteriovenous anastomotic blood flow in the human hand and forearm and in the pig hind leg. J Cardiovasc Pharmacol (1991) 0.85
Differences between exogenous and endogenous noradrenaline in the effects on vascular post-synaptic alpha 1- and alpha 2-adrenoceptors in man. J Hypertens Suppl (1985) 0.85
Subclinical renal dysfunction in rheumatoid arthritis. Arthritis Rheum (1990) 0.85
Digoxin-like immunoreactive substance in patients with aneurysmal subarachnoid haemorrhage. Br Med J (Clin Res Ed) (1987) 0.84
Pharmacokinetics and hemodynamic effects of long-term nifedipine treatment in hypertensive patients. J Cardiovasc Pharmacol (1987) 0.84
Functional and structural determinants of glomerulosclerosis in the fawn-hooded rat. Eur J Clin Invest (1992) 0.83
Oral absorption profile of nitrendipine in healthy subjects: a kinetic and dynamic study. Br J Clin Pharmacol (1989) 0.83
The influence of infusion rate on the pharmacokinetics and haemodynamic effects of nisoldipine in man. Br J Clin Pharmacol (1988) 0.83
Arterial and venous effects of serotonin in the forearm of healthy subjects are not age-related. J Cardiovasc Pharmacol (1989) 0.82
Apparent mineralocorticoid excess and deficient 11 beta-oxidation of cortisol in a young female. Clin Endocrinol (Oxf) (1984) 0.82
Dose-dependent pharmacokinetics of metoclopramide in rat: an effect of hemoperfusion? J Pharmacol Exp Ther (1981) 0.82
Moclobemide excretion in human breast milk. Br J Clin Pharmacol (1990) 0.82
The effect of fludrocortisone acetate on plasma volume and natriuresis in patients with aneurysmal subarachnoid hemorrhage. Clin Neurol Neurosurg (1988) 0.82
Alpha 1-and alpha 2-adrenoceptor mediated vasoconstriction in the forearm of normotensive and hypertensive subjects. J Cardiovasc Pharmacol (1986) 0.82
Ethnopharmacology of rhinoceros horn. II: Antipyretic effects of prescriptions containing rhinoceros horn or water buffalo horn. J Ethnopharmacol (1991) 0.82
Phylogenetic relationships and evolutionary history of the shrimp genus Penaeus s.l. derived from mitochondrial DNA. Mol Phylogenet Evol (2004) 0.82
Propofol and thiopental in a 1:1 volume mixture is chemically stable. Anesth Analg (1998) 0.82
Expression of SCM-1alpha/lymphotactin and SCM-1beta in natural killer cells is upregulated by IL-2 and IL-12. DNA Cell Biol (1999) 0.81
Influence of single- and multiple-dose omeprazole treatment on nifedipine pharmacokinetics and effects in healthy subjects. Eur J Clin Pharmacol (1992) 0.81
Vascular alpha-adrenoceptors in man: interactions with adrenaline and noradrenaline. Clin Sci (Lond) (1985) 0.81
Character of adverse effects of prophylactic lidocaine in the coronary care unit. Clin Pharmacol Ther (1986) 0.81
Effects of PN 200-110, a new calcium antagonist, on alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction elicited by selective alpha-adrenoceptor agonists and catecholamines in the pithed rat. Arch Int Pharmacodyn Ther (1985) 0.81
Arterial dilatation and venous constriction induced by serotonin in the elderly. Drugs (1988) 0.80
Pharmacokinetics and hemodynamic effects of nisoldipine and its interaction with cimetidine. Clin Pharmacol Ther (1988) 0.80
5HT3 receptor-mediated vasodilation in the human forearm. J Hypertens Suppl (1988) 0.80
Linearity of metoclopramide kinetics at doses of 5-20 mg. Br J Clin Pharmacol (1988) 0.80
Nonparallel effects of renin inhibitor treatment on plasma renin activity and angiotensins I and II in hypertensive subjects. An assay-related artifact. Am J Hypertens (1991) 0.80
Serotonergic receptors and drugs in hypertension. Pharmacol Toxicol (1992) 0.79
Reassessing models of hepatic extraction. J Biol Phys (2003) 0.79
Arterial and venous effects of atrial natriuretic peptide in the human forearm. Am J Hypertens (1991) 0.79
Acetylation and pentafluorobenzoylation of lidocaine metabolites in aqueous solution and identification of derivatives by combined gas chromatography/mass spectrometry. Biomed Environ Mass Spectrom (1987) 0.79
Sodium sensitivity in essential hypertension: role of the renin-angiotensin-aldosterone system and predictive value of an intravenous frusemide test. J Hypertens (1984) 0.79
Bartter's syndrome: an autosomal recessive disorder? Study of four patients in one generation of the same pedigree and their relatives. Acta Med Scand (1981) 0.79
Pathophysiological and pharmacotherapeutic aspects of serotonin and serotonergic drugs. Clin Physiol Biochem (1990) 0.79
Demonstration of neuronal and extraneuronal uptake of circulating norepinephrine in the forearm. Hypertension (1987) 0.79
Sympathetic activity and presynaptic adrenoceptor function in patients with longstanding essential hypertension. J Hypertens (1994) 0.79
The pharmacokinetics of captopril in infants with congestive heart failure. Ther Drug Monit (1991) 0.79
An interactive computer program for determining areas bounded by drug concentration curves using lagrange interpolation. J Pharmacol Toxicol Methods (1995) 0.79
Nisoldipine: kinetics and effects on blood pressure and heart rate in patients with liver cirrhosis after intravenous and oral administration. Eur J Clin Pharmacol (1988) 0.78
Effect of haemodialysis on metoclopramide kinetics in patients with severe renal failure. Br J Clin Pharmacol (1988) 0.78
Effect of the renin response during renin inhibition: oral Ro 42-5892 in normal humans. J Cardiovasc Pharmacol (1991) 0.78
Double-blind comparison of the cardioselective beta-blockers bisoprolol and atenolol in hypertension: the Bisoprolol International Multicenter Study (BIMS). J Cardiovasc Pharmacol (1986) 0.78
The effect of a converting enzyme inhibitor upon renal damage in spontaneously hypertensive Fawn Hooded rats. J Hypertens (1992) 0.78
Osmotic load from glucose polymers. JPEN J Parenter Enteral Nutr (1991) 0.78
Local hemodynamic effects of serotonin and ketanserin in healthy subjects: studies in the forearm. J Cardiovasc Pharmacol (1988) 0.78
Models of hepatic drug elimination. Drug Metab Rev (1992) 0.78
Influence of hydrochlorothiazide on the plasma levels of triglycerides, total cholesterol and HDL-cholesterol in patients with essential hypertension. Curr Med Res Opin (1979) 0.78
Nonlinear pharmacokinetics of mibefradil in the dog. J Pharm Sci (1996) 0.78
The effect of acute ACE inhibition on atrial natriuretic peptide. Br J Clin Pharmacol (1989) 0.78
Plasma lipid fractions during bopindolol treatment in hypertensive patients. J Cardiovasc Pharmacol (1986) 0.78
Dosimetry estimations for 123I-IAZA in healthy volunteers. J Nucl Med (2001) 0.77
Simplified determination of captopril in plasma by high-performance liquid chromatography. J Chromatogr (1988) 0.77
Iron-loaded PLLA nanoparticles as highly efficient intracellular markers for visualization of mesenchymal stromal cells by MRI. Contrast Media Mol Imaging (2014) 0.77
Clinical biochemical and haemodynamic correlates of sodium sensitivity in essential hypertension. J Hypertens Suppl (1983) 0.77
Alpha 1- and alpha 2-adrenoceptor mediated vasoconstriction in the forearm: differences between normotensive and hypertensive subjects. J Hypertens Suppl (1985) 0.77
Serotonin induced vasodilatation in the human forearm is antagonized by the selective 5-HT3 receptor antagonist ICS 205-930. Life Sci (1988) 0.77
Pharmacological profile of antihypertensive drugs with serotonin receptor and alpha-adrenoceptor activity. Drugs (1990) 0.77
Effects of intravenous infusion of lidocaine on its pharmacokinetics in conscious instrumented dogs. J Pharm Sci (1997) 0.77
Clinical pharmacokinetics of 123I-IAZA in healthy volunteers. Nucl Med Commun (1999) 0.76